Encainide Hydrochloride

盐酸恩卡尼

Report date: 2023/04/21 17:47:01
NME

Base Information

Drug NameEncainide Hydrochloride
Drug Alias Name恩卡尼EnkaidMJ-9067-1MJ-9067 (freebase)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockers
TargetsSodium channel alpha subunit
Therapy Area/IndicationsBradycardiaArrhythmias, CardiacHeart Diseases +[4
Global Approved IndicationsBradycardia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1986/01/01
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsBradycardia
Inactive IndicationsArrhythmias, CardiacHeart DiseasesCardiovascular Diseases

Other Information

ATC CodeC01BC08